Dementia and Parkinson’s: What We Know and How We’re Trying to Stop It

August 20, 2015

A great concern of people with Parkinson’s is disease impact on the mind. In this webinar we’ll cover what we know about what happens in the brain and what clinical symptoms may present with mild cognitive impairment and dementia with Parkinson’s disease. We’ll also discuss available treatments and new therapies in development to prevent or lessen these symptoms.

Webinar Details

Date:

Thursday, August 20, 2015

Duration:

1 hr

Time:

12:00 pm ET

Dementia and Parkinson’s: What We Know and How We’re Trying to Stop It

First Name

Last Name

Postal Code

What is your primary connection to Parkinson's?

What Year Were You Diagnosed with PD?

Do you have a question you would like to submit in advance?

You must have Javascript and Cookies enabled in your browser preferences to access this webinar.

By registering you agree to receive email updates from The Michael J. Fox Foundation. You can unsubscribe any time.

Panelists

Jamie Eberling, PhD
Jennifer G. Goldman, MD, MS

Associate Professor, Section of Parkinson's Disease and Movement Disorders, Department of Neurological Sciences, Rush University Medical Center
Disclosures: Advisory Role at Acadia, Teva and Pfizer
Maggie McGuire

Moderator

Animations

Dementia and Parkinson’s: What We Know and How We’re Trying to Stop It

August 20, 2015

Webinar Details

Date:

Duration:

Time:

Panelists

Jamie Eberling, PhD

Jennifer G. Goldman, MD, MS

Associate Professor, Section of Parkinson's Disease and Movement Disorders, Department of Neurological Sciences, Rush University Medical Center Disclosures: Advisory Role at Acadia, Teva and Pfizer

Maggie McGuire

Moderator

Associate Professor, Section of Parkinson's Disease and Movement Disorders, Department of Neurological Sciences, Rush University Medical Center
Disclosures: Advisory Role at Acadia, Teva and Pfizer